logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Tübingen University Hospital

+497071290
support-mp@medizin.uni-tuebingen.de
Source: Site record.
https://www.medizin.uni-tuebingen.de

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Tübingen University Hospital (Universitätsklinikum Tübingen) is one of Germany's premier academic medical centres, renowned for combining high-performance maximum-care medicine, breakthrough scientific research, and elite medical education. Founded in 1805, it ranks consistently among the top five hospitals in Germany according to major publications like Focus.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Trial-derived.
67Total Trials
Source: Trial-derived.
23Recruiting Trials
Source: Trial-derived.
25Active Trials
Source: Trial-derived.
1Completed Trials
Source: Trial-derived.
94Unique Conditions
Source: Trial-derived.
116Unique Sponsors

Conditions

Source: Trial-derived. Parkinson's Disease (3)Source: Trial-derived. Acute Myeloid Leukemia (AML) (2)Source: Trial-derived. Multiple Myeloma (2)Source: Trial-derived. Neoplasm Metastasis (2)Source: Trial-derived. Peripheral Arterial Disease (2)Source: Trial-derived. Acetabular Fractures (1)Source: Trial-derived. Acute Lymphoblastic Leukemia (1)Source: Trial-derived. Acute Lymphoblastic Leukemia, Pediatric (1)

Sponsors

Source: Trial-derived. University Hospital Tuebingen (18)Source: Trial-derived. Hoffmann-La Roche (4)Source: Trial-derived. German Cancer Research Center (3)Source: Trial-derived. Medtronic (3)Source: Trial-derived. AbbVie (2)Source: Trial-derived. Amgen (2)Source: Trial-derived. Charite University, Berlin, Germany (2)Source: Trial-derived. Daiichi Sankyo (2)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Blood transfusion service
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Intensive care (ICU)
Source: AI-inferred. Invasive mechanical ventilation

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Chest radiological imaging
Source: AI-inferred. Respiratory virus diagnostic testing
Source: AI-inferred. Visual acuity testing